SpaceX Stock Is Already Down 37% From Its Peak. Here's What Deutsche Bank's $255 Target Says Happens Next

SpaceX shares (SPCX) fell about 37.5% from the mid-June peak around $225.64 to roughly $141, slipping below the ~$150 debut level—framed as a sentiment unwind after IPO hype rather than a business deterioration. Deutsche Bank initiated/maintained a buy stance with a $255 price target, implying substantial upside (~+80% vs. ~$141) based on reusable, cheaper launch economics and Starlink’s growth into global connectivity plus potential in-orbit/ground computing. Offsetting this, the article flags very high valuation headroom constraints and heavy reliance on Starlink while Starship remains in progress, making the outlook optimistic but uncertain.

Analysis

This is primarily a flow event, not a fundamental reset. The first-order loser is momentum capital that paid up for a scarce-space narrative; the second-order losers are adjacent space-tech comps that trade on the same “secular inevitability” multiple and can de-rate when the market stops rewarding optionality. The real business winners, if the operating metrics keep compounding, are patient institutional buyers who can underwrite a multi-year platform rather than a debut-week tape, but they should demand evidence that monetization is outrunning capex.

The risk path is asymmetric because the valuation still embeds perfection while the operating model remains multi-variable: launch reliability, Starlink adoption, government/enterprise mix, and funding needs all have to cooperate. Near term, the key catalyst is whether the stock can stabilize above the post-debut support area after the mechanical buying has fully cleared; if not, a drift back toward issue price can persist for weeks as performance-chasing holders exit. Over 1-3 months, any disclosure on subscriber growth, ARPU, or launch cadence will matter more than analyst targets; over 6-18 months, a Starship slip or equity raise is the real multiple-compression trigger.

The contrarian miss is that the market may be overreacting to the price chart while underpricing the competitive moat, but it may also be underestimating dilution risk and the fact that this is a bundle of unproven bets, not a single clean franchise. I would treat this as a watch item, not a blanket buy-the-dip, unless the next operating update confirms that Starlink can scale without forcing another capital call. For public-market spillovers, legacy satellite names remain structurally challenged by the competitive threat; the recent selloff in the equity does not improve their long-term earnings power.

Key Decisions for Investors

• Stay flat SPCX for now; avoid chasing the bounce until price reclaims the post-debut support area and holds for 2+ sessions. Falsifier: a decisive break below the offer zone that triggers another leg of supply.
• If SPCX reclaims $150 on improving operating disclosures, buy a small 3-6 month call spread rather than outright stock to cap valuation risk; target a 2:1+ payoff into the analyst target range, but cut if guidance disappoints.
• Use any relief rally in legacy satellite beneficiaries/competitors such as VSAT and IRDM to initiate or add to shorts on the thesis that Starlink’s competitive pressure is unchanged despite SPCX volatility. Time horizon: 1-3 months.
• Set alerts for the next Starlink/launch update, secondary sale rumor, or equity financing discussion; those are the catalysts that can either validate the long thesis or force a rapid de-rating within days.
• No trade on DB itself; the coverage call is sentiment support, not a monetizable earnings event, unless the firm materially increases underwriting/advisory activity in the space-tech stack.